eli lilly glp 1 injection releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity This GLP-1 Is the Most

GLP-1 and the Food Industry: Challenges & Opportunities Although positive for the consumer from the weight loss perspective, the full implications of GLP-1 drugs are yet to be seen

An assessment tool such as the ADA risk test (diabetes.org/socrisktest) is recommended to guide providers on whether performing a diagnostic test for prediabetes or previously undiagnosed type 2 diabetes is appropriate

Marketing materials saturated digital, print, and broadcast media with messages about life-changing weight loss while omitting meaningful risk disclosures about potential permanent digestive dysfunction

Which GLP-1 Medication Is Right for You